Company
Innoblative
Developing advanced energy-based surgical solutions
Also known as Innoblative Designs, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Chicago, IL, United States
- Customers
- surgeons
- Legal name
- Innoblative Designs, Inc.
- innoblative.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Innoblative, a private medical device company addressing unmet clinical needs for patients with breast cancer and other soft tissue diseases, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company's SIRA® RFA Electrosurgical Device.
Funding snapshot
- Total raised
- $9.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Grant, $100K2016
Funding rounds
- Round, 2017
- $7.2M2017-04-21, SEC form D sold, 37 investors
- Round, 2016
- $1M2016-04-13, SEC form D sold, 1 investor
- Grant
- $100K2016, Company stated
- Round, 2014
- $1.2M2014-06-22, SEC form D sold, 21 investors
Products
- Hardware
- SIRA® RFA Electrosurgical Device
Loading relationship preview